Home
About IBT
Vision and Mission
IBT History
Management
Board of Directors
Advisory Board
Families
Families
Health Care Professionals
Pipeline
IBP-9414
IBP-1016
Investors & Media
Shares
Presentations
Share Issue
Ownership Structure
Corporate Governance
Calendar
Financial Reports
Press Releases
News
Investors & Media Contact
Subscribe
Contact Us
Career
En
Sv
Home
About IBT
Vision and Mission
IBT History
Management
Board of Directors
Advisory Board
Families
Families
Health Care Professionals
Pipeline
IBP-9414
IBP-1016
Investors & Media
Shares
Presentations
Share Issue
Ownership Structure
Corporate Governance
Calendar
Financial Reports
Press Releases
News
Investors & Media Contact
Subscribe
Contact Us
Career
Press releases
Outcome of Infant Bacterial Therapeutics’ rights issue
To access the press release, please read the following disclaimer
here
.
February 2, 2018
Latest press releases
Infant Bacterial Therapeutics receives additional patent protection in China
Infant Bacterial Therapeutics publishes Annual Report for 2020
Notice to attend the Annual General Meeting of Infant Bacterial Therapeutics
Infant Bacterial Therapeutics announces that the recruitment to the first stage of the Phase III Connection Study is completed – an update about the clinical development of IBP-9414
Infant Bacterial Therapeutics today announces that new patent protection is granted in Japan
This site uses cookies – small text-based files that are placed on your device to help us provide a better user experience.
Find out more.
Okay, thanks